期刊文献+

正常核型成人急性髓系白血病的基因突变谱及其临床特征分析 被引量:2

Spectrum of gene mutationsandclinical features in adult acute myeloid leukemia with normal karyotype
原文传递
导出
摘要 急性髓系白血病(AML)是以髓系原始细胞克隆性增殖及分化受阻,抑制正常造血为特征的异质性疾病[1-2]。40%~50%的AML患者为正常核型(normal karyotype,NK)[1,3-5],此类患者预后同样具有异质性,伴有众多的基因突变,可能影响化疗方案的选择[3]。应用靶向基因测序技术有助于检出多重体细胞突变基因。近年研究发现PLT与白血病细胞的恶性增殖及干性维持密切相关,我们的前期研究结果提示,AML初诊时外周血PLT较高可能与不良预后相关[6-7],其他学者亦有类似报道[8-9]。本研究中我们对134例NK-AML初发标本进行基因突变检测,以探究其基因谱系改变及初发时PLT特征。
作者 黄爱杰 高磊 倪雄 胡晓霞 唐古生 程辉 陈洁 陈莉 刘丽霞 王程程 章卫平 杨建民 王健民 Huang Aijie;Gao Lei;Ni Xiong;Hu Xiaoxia;Tang Gusheng;Chenghui;Chen Jie;Chen Li;Liu Lixia;Wang Chengcheng;Zhang Weiping;Yang Jianmin;Wang Jianmin(Department of Hematology,Institute of Hematology,the First Affiliated Hospital of Navy Military Medical University(Changhai Hospital),Shanghai 200433;Acornmed Biotechnology Co.,Ltd.Beijing,100176)
出处 《中华血液学杂志》 CAS CSCD 北大核心 2021年第5期420-424,共5页 Chinese Journal of Hematology
基金 国家自然科学基金(81870143、81530047、81770160、81771779) 上海市卫生计生系统百人计划(2017BR012) 海军军医大学第一附属医院青年启动基金(2020QNA03)。
  • 相关文献

参考文献7

二级参考文献25

  • 1张悦,邵英起,薛永权,王一,张美荣,刘旭平,郑以州,肖志坚.伴有t(3;5)(q25;q34)的骨髓增生异常综合征急性髓系白血病变患者的分子特征[J].中华血液学杂志,2006,27(12):833-837. 被引量:6
  • 2钱思轩,李建勇,沈云峰,蒋元强,陆化,吴汉新,徐卫,程蕴琳,盛瑞兰.CAG预激方案治疗老年人急性髓细胞白血病的临床观察[J].中华老年医学杂志,2007,26(4):248-250. 被引量:39
  • 3Slovak ML, Kopecky KJ, Cassileth PA, et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/ Eastern Cooperative Oncology Group Study[J]. Blood, 2000, 96 (13) :4075-4083.
  • 4Kiyoi H, Naoe T, Nakano Y, et al. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia[J]. Blood, 1999,93(9):3074-3080.
  • 5Ma W, Kantarjian H, Zhang X, et al. Detection of nucleophosmin gene mutations in plasma from patients with acute myeloid leukemia: clinical significance and implications [J]. Cancer Biornark, 2009, 5( 0:51-58.
  • 6Cheson BD, Cassileth PA, Head DR, et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia [J]. J Clin Oncol, 1990,8(5 ):813-819.
  • 7Beran M, Luthra R, Kantarjian H, et al. FLT3 mutation and response to intensive chemotherapy in young adult and elderly patients with normal karyotype[J]. Leuk Res, 2004, 28(6):547- 550.
  • 8Friihling S, Schlenk RF, Breitruck J, et al. Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm [J]. Blood, 2002, 100 ( 13 ) : 4372-4380.
  • 9Chou WC, Tang JL, Lin LI, et al. Nucleophosmin mutations in de novo acute myeloid leukemia: the age- dependent incidences and the stability during disease evolution [J]. Cancer Res, 2006, 66( 6) :3310-3316.
  • 10Thiede C, Koch S, Creutzig E, et al. Prevalence and prognostic impact of NPMI mutations in 1485 adult patients with acute myeloid leukemia (AML) [J]. Blood, 2006, 107 (l0):4011- 4020.

共引文献425

同被引文献22

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部